CA
BBNX

Cliff Asness’s Beta Bionics BBNX Stock Holding History

Cliff Asness’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.83M Buy
308,468
+248,181
+412% +$2.95M ﹤0.01% 2027
2026
Q1 		$604K Buy
60,287
+9,882
+20% +$146K ﹤0.01% 3024
2025
Q4 		$1.54M Sell
50,405
-1,605
-3% -$42.9K ﹤0.01% 2308
2025
Q3 		$1.03M Sell
52,010
-3,423
-6% -$60.2K ﹤0.01% 2416
2025
Q2 		$807K Buy
+55,433
New +$785K ﹤0.01% 2326

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Cliff Asness's BBNX Position: Q2 2026 in Review

Cliff Asness increased its Beta Bionics (BBNX) stake by 412% in Q2 2026, buying an estimated $2.95M and bringing the position to 308,468 shares worth $4.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2027.

Cliff Asness first reported a position in BBNX in Q2 2025 and has held it in 5 quarters since. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Cliff Asness held 308,468 shares of Beta Bionics worth $4.83M as of Q2 2026.
  • Cliff Asness bought 248,181 Beta Bionics shares in Q2 2026, an estimated $2.95M.
  • Beta Bionics made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2027 holding.
  • Cliff Asness first reported a position in Beta Bionics in Q2 2025 and has held it in 5 quarters since.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.